A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
Clinical trial NCT06660654 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06660654
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2027-09-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.